跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GLP-26
首页
药物
GLP-26
GLP-26
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Glucagon/GLP-1 receptor co-agonists
US 8454971 B2
申请人: DAY JONATHAN
优先权: 2008
EP
US
7 件公开
US 8546327 B2
申请人: DIMARCHI RICHARD D
优先权: 2008
CN
US
5 件公开
Double-acylated GLP-1 derivatives
US 8648041 B2
申请人: GARIBAY PATRICK WILLIAM
优先权: 2009
CN
US
6 件公开
US 2015133374 A1
申请人: NOVO NORDISK AS
优先权: 2013
CN
US
4 件公开
US 2015152157 A1
申请人: NOVO NORDISK AS
优先权: 2013
CN
US
3 件公开
Glucagon-like peptide-1 analogues and uses thereof
US 8951959 B2
申请人: WANG YINXIANG
优先权: 2010
CN
EP
US
WO
5 件公开
TRUNCATED GLP-1 DERIVATIES AND THEIR THERAPEUTICAL USE
US 2010292133 A1
申请人: NOVO NORDISK AS
优先权: 2007
CN
US
4 件公开
GLP-1 derivative and preparation thereof absorbable via mucous membrane
US 7291594 B2
申请人: SANWA KAGAKU KENKYUSHO CO
优先权: 2002
US
2 件公开
Shortened glucagon-like peptide 1(sGLP-1) preparation method and application
US 7834142 B2
申请人: DALIAN D N BIO ENGINEERING CO
优先权: 2005
US
2 件公开
US 2011144012 A1
申请人: DALIAN D N BIO ENGINEERING CO LTD
优先权: 2010
US
GLP-1 derivatives, and uses thereof
US 10266577 B2
申请人: NOVO NORDISK AS
优先权: 2014
US
Synthesis method of acylated GLP-1 compound and modified gene thereof
CN 111378028 A
申请人: WANXIN PHARMACEUTICAL TECH SUZHOU CO LTD
优先权: 2018
CN
GLP-1 analogs
CN 114957443 A
申请人: SHANGHAI INST PHARMACEUTICAL IND
优先权: 2021
CN
Method for synthesizing semeglutide through one-pot method
CN 120718132 A
申请人: HYBIO PHARMACEUTICAL CO LTD
优先权: 2024
CN
第 1 / 2 页
上一页
下一页
药物
反馈